You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Les traitements par chimiothérapie et autres traitements systémiques pourraient être modifiés en raison de la COVID-19. Vous trouverez de plus amples renseignements à la page Traitements systémiques pendant la pandémie de la COVID-19.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

ribociclib

( rye-boe-SYE-klib )
Funding:
Exceptional Access Program
  • ribociclib - First-line treatment of hormone receptor positive, human epidermal growth factor receptor 2 (HER 2)-negative unresectable locally advanced breast cancer or metastatic breast cancer, with specific criteria
Other Name(s): Kisqali™
Appearance: Tablet.    

Patient Info Sheet

Sep 2019

What it is used for

For treating advanced breast cancer that may not be able to be removed by surgery or has spread to other parts of the body, in combination with another medication



You might also be interested in